Fractyl Health, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Fractyl Health, Inc. (GUTS) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$1.89 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-10
- Fractyl Health, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $1.04M, a 69.54% increase year-over-year.
- Fractyl Health, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$2.93M, a 475.51% decline year-over-year.
- Fractyl Health, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was -$169.00K, a 106.46% decline year-over-year.
- Fractyl Health, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$811.00K, a 141.08% decline year-over-year.
- Fractyl Health, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $414.00K, a 92.68% decline from fiscal 2024.
- Fractyl Health, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $5.65M, a 941.25% increase from fiscal 2023.
- Fractyl Health, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $543.00K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.89M 10-Q · filed 2026-08-10 | -$2.06M derived: sum of 3 quarters · filed 2026-08-10 | -$2.87M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$2.93M 10-Q · filed 2026-05-12 | -$3.10M derived: sum of 2 quarters · filed 2026-05-12 | -$3.91M derived: sum of 3 quarters · filed 2026-05-12 | -$3.29M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$980.00K derived: sum of 2 quarters · filed 2026-03-24 | -$366.00K derived: sum of 3 quarters · filed 2026-08-10 | $414.00K 10-K · filed 2026-03-24 |
| 2025-09-30 | -$811.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$197.00K derived: sum of 2 quarters · filed 2026-08-10 | $583.00K 10-Q · filed 2025-11-12 | $3.20M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $614.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.39M 10-Q · filed 2026-08-10 | $4.01M derived: sum of 3 quarters · filed 2026-08-10 | $5.99M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $780.00K 10-Q · filed 2026-05-12 | $3.40M derived: sum of 2 quarters · filed 2026-05-12 | $5.37M derived: sum of 3 quarters · filed 2026-05-12 | $3.58M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $4.59M derived: sum of 2 quarters · filed 2026-03-24 | $2.80M derived: sum of 3 quarters · filed 2026-03-24 | $5.65M 10-K · filed 2026-03-24 |
| 2024-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $182.00K derived: sum of 2 quarters · filed 2025-11-12 | $3.04M 10-Q · filed 2025-11-12 | $3.40M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.06M 10-Q · filed 2025-08-12 | $1.43M derived: sum of 3 quarters · filed 2025-08-12 | $1.51M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $2.85M 10-Q · filed 2025-05-13 | $3.22M derived: sum of 2 quarters · filed 2025-05-13 | $3.30M derived: sum of 3 quarters · filed 2025-05-13 | $2.43M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $367.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $445.00K derived: sum of 2 quarters · filed 2025-03-03 | -$422.00K derived: sum of 3 quarters · filed 2025-03-03 | $543.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$789.00K derived: sum of 2 quarters · filed 2024-11-12 | $176.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$867.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $98.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $965.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |